Localized large B-cell lymphoma with MYC and BCL6 rearrangements as an unexpected finding in an appendectomy specimen

被引:0
|
作者
Poltorak, Przemyslaw Marcin [1 ]
Plesner, Trine Lindhardt [2 ]
Petersson, Eva Stampe [2 ]
Schejbel, Lone [3 ]
Breinholt, Marie Fredslund [3 ]
Lode, Lise [4 ]
Hutchings, Martin [5 ]
Norgaard, Peter [1 ]
机构
[1] Univ Copenhagen, Dept Pathol, Hosp Hvidovre, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark
[2] Rigshosp, Copenhagen Univ Hosp, Dept Pathol, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Pathol, Hosp Herlev, Herlev, Denmark
[4] Univ Copenhagen, Surg Sect, Gastrounit, Hosp Hvidovre, Hvidovre, Denmark
[5] Rigshosp, Copenhagen Univ Hosp, Dept Haematol, Copenhagen, Denmark
关键词
Appendix; double-hit lymphoma; HGBL; c-myc; bcl6; HEALTH-ORGANIZATION CLASSIFICATION; OUTCOMES;
D O I
10.1111/apm.13492
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Large B-cell lymphomas (LBLs) comprise a genetically heterogeneous group of clinically aggressive non-Hodgkin lymphomas, frequently exhibiting overlapping features with diffuse large B-cell lymphoma and Burkitt's lymphoma. We report a case of a 24-year-old, previously healthy male with a classical clinical presentation of acute appendicitis. The pathologic examination discovered a large B-cell lymphoma with MYC and BCL6 rearrangements in the excised appendix. The patient was assigned Stage IEA, IPI = 0 and received chemotherapy. This case depicts a very uncommon occurrence of fully localized LBL in a patient of an unusually young age and clinical presentation for this type of lymphoma.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
    Horn, Heike
    Ziepert, Marita
    Becher, Claudia
    Barth, Thomas F. E.
    Bernd, Heinz-Wolfram
    Feller, Alfred C.
    Klapper, Wolfram
    Hummel, Michael
    Stein, Harald
    Hansmann, Martin-Leo
    Schmelter, Christopher
    Moeller, Peter
    Cogliatti, Sergio
    Pfreundschuh, Michael
    Schmitz, Norbert
    Truemper, Lorenz
    Siebert, Reiner
    Loeffler, Markus
    Rosenwald, Andreas
    Ott, German
    BLOOD, 2013, 121 (12) : 2253 - 2263
  • [22] Gemcitabine, Dexamethasone, and Cisplatin Regimen as an Effective Salvage Therapy for High-grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements
    Mitobe, Masaki
    Kawamoto, Keisuke
    Suzuki, Takaharu
    Kiryu, Maiko
    Tamura, Suguru
    Nanba, Ayako
    Suwabe, Tatsuya
    Tanaka, Tomoyuki
    Fuse, Kyoko
    Shibasaki, Yasuhiko
    Masuko, Masayoshi
    Miyoshi, Hiroaki
    Ohshima, Koichi
    Sone, Hirohito
    Takizawa, Jun
    INTERNAL MEDICINE, 2019, 58 (04) : 575 - 580
  • [23] Patients with double/triple copy number gains on C-MYC, BCL2, and/or BCL6 treated with standard chemotherapy have a similarly poor prognosis than those with high-grade B cell lymphoma with C-MYC and BCL2 and/or BCL6 rearrangements: a single-center experience on a consecutive cohort of large B cell lymphomas
    Willenbacher, Ella
    Willenbacher, Wolfgang
    Weger, Roman
    Dominik, Wolf
    Manzl, Claudia
    Brunner, Andrea
    ANNALS OF HEMATOLOGY, 2020, 99 (09) : 2125 - 2132
  • [24] EBV+ high-grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a multi-institutional study
    Liu, Hui
    Xu-Monette, Zijun Y.
    Tang, Guilin
    Wang, Wei
    Kim, Young
    Yuan, Ji
    Li, Yu
    Chen, Weina
    Li, Yanping
    Fedoriw, George Y.
    Zhu, Feng
    Fang, Xiaosheng
    Luedke, Catherine
    Medeiros, L. Jeffrey
    Young, Ken H.
    Hu, Shimin
    HISTOPATHOLOGY, 2022, 80 (03) : 575 - 588
  • [25] Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements Clinicopathologic Features of 11 Cases
    Wang, Wei
    Hu, Shimin
    Lu, Xinyan
    Young, Ken H.
    Medeiros, L. Jeffrey
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (08) : 1132 - 1139
  • [26] High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma
    Rosenthal, Allison
    Younes, Anas
    BLOOD REVIEWS, 2017, 31 (02) : 37 - 42
  • [27] Case of B-Cell lymphoma with rearrangement of the BCL1, BCL2, BCL6, and c-MYC genes
    Kawakami, K
    Miyanishi, S
    Sonoki, T
    Nakamura, S
    Nomura, K
    Taniwaki, M
    Murata, T
    Kadowaki, S
    Kadowaki, N
    Miura, I
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (05) : 474 - 479
  • [28] DA-EPOCH-R therapy for high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements in a patient with renal dysfunction
    Mitobe, Masaki
    Kawamoto, Keisuke
    Suzuki, Takaharu
    Suwabe, Tatsuya
    Shibasaki, Yasuhiko
    Masuko, Masayoshi
    Inoue, Kanako
    Miyoshi, Hiroaki
    Ohshima, Koichi
    Sone, Hirohito
    Takizawa, Jun
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2021, 61 (01) : 42 - 47
  • [29] Cutaneous Involvement in a High Grade B-Cell Lymphoma With Rearrangement of MYC, BCL2, and BCL6 Transformed From Follicular Lymphoma
    Martinez-Mera, C.
    Herrero-Moyano, M.
    Lopez-Elzaurdia, C.
    Loscertales, J.
    Aragues, M.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2019, 41 (01) : 80 - 82
  • [30] C-MYC, BCL2 and BCL6 Translocation in B-cell Non-Hodgkin Lymphoma Cases
    Salam, Dayang Sharyati Datu Abdul
    Thit, Ei Ei
    Teoh, Siew Hoon
    Tan, Soo Yong
    Peh, Suat Cheng
    Cheah, Shiau-Chuen
    JOURNAL OF CANCER, 2020, 11 (01): : 190 - 198